trimethoprim has been researched along with Nasopharyngeal Neoplasms in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ross, IN | 1 |
| Thompson, RA | 1 |
| Asquith, P | 1 |
1 other study available for trimethoprim and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Alpha heavy chain disease developing in an Asian resident in the United Kingdom and responding to antibiotics.
Topics: Adult; Anti-Infective Agents, Urinary; Drug Combinations; Heavy Chain Disease; Humans; Immunoglobuli | 1983 |